SRWA Medicaid PDL Report Published

Medicaid Preferred Drug List report by S. R. Ware Associates, Inc. is a comprehensive, targeted and informative data source for pharmaceutical government affairs, managed care, and field sales managers.

  • Share ThisShareThis Email Contact Email PDF Version PDF Printer Friendly Version Print

Downingtown, PA (PRWEB) January 13, 2005

Medicaid Preferred Drug Lists continue to be the hot topic in 2005. As more and more states develop and implement a preferred drug list (PDL), it becomes doubly important for anyone with responsibility for Medicaid pharmaceutical sales to know “what’s happening.” S. R. Ware Associates, Inc. unique and comprehensive report on Medicaid PDL updated report will be available after January 20, 2005.

Most pharmaceutical companies have Medicaid preferred drug list, prior authorization criteria, supplemental rebate information, and contact information stored somewhere residing in the company’s database, but very few have this information available as a single comprehensive report. SRWA can bring it all together for your pharmaceutical company, large or small.

Releasing a new product? No problem – we bookmark every state with your therapeutic category and tell you whether you have the competitive advantage or whether there are barriers to entry.

Concerned about competitor activities in the Medicaid market? No problem – we provide up to date information about every drug listed on preferred drug lists four times a year.

Know when your therapeutic category will be reviewed? No problem – we list every state’s schedule and tell you when your drug will be reviewed.

Need a custom report for your specific market? No problem – we can provide prior authorization criteria, therapeutic category reviews, and other information on a custom basis and quick turn-around.

The SRWA Report

Call SRWA for a sample PDL report and find out why so many pharmaceutical companies rely on our service. SRWA reports feature:

  • Combines all the Medicaid information you need into one searchable report
  • Describes specific therapeutic categories Medicaid will review
  • Analyses co-payments and tiered payment schemes
  • PDF version is searchable by state and therapeutic category

SRWA has considerable pharmaceutical industry experience working with state Medicaid programs. We are experts in:

  • Developing state specific action plans
  • Calling on Medicaid officials to coordinate your strategic objective
  • Cultivating and developing opinion leaders

Contact SRWA for information on how to subscribe, pricing, delivery options, custom reports, and details to exactly fit your information needs.

About S. R. Ware Associates, Inc.

S. R. Ware Associates, Inc. (SRWA) is a contract consultant group focused on pre- and post-launch pharmaceutical, biotechnology, or laboratory products requiring approval from Medicaid, Medicare, or other entities. Steve Ware, who is a 25-year veteran in pharmaceutical sales, market research, knowledge management, and opinion leader development, founded SRWA in 1995. SRWA draws upon a cadre of experienced associates with expertise in lobbying, sales management, advocacy, and a variety of therapeutic areas.

###


Contact

  • Steve Ware
    S. R. WARE ASSOCIATES, INC.
    610-321-6191
    Email

Attachments

SRWA Preferred Drug List Report SRWA Preferred Drug List Report
New Medicaid Report on Preferred Drug Lists



Past News Releases Group Rss Subscribe